Wells Fargo’s Select Medical SEM Stock Holding History

Wells Fargo’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-241,280	Closed	-$581K	–	6542
2017 Q4	$581K	Hold	241,280	–	–	﹤0.01%	4287
2017 Q3	$557K	Buy	+241,280	New	+$2.23M	﹤0.01%	4256

Other funds holding SEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo's SEM Position: Q1 2026 in Review

Wells Fargo reduced its Select Medical (SEM) stake by 65% in Q1 2026, selling an estimated $1.25M and leaving 43,438 shares worth $708K. The position accounts for ﹤0.01% of the portfolio, ranked #3951.

Wells Fargo first reported a position in SEM in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.9M in Q1 2016. 277 funds tracked by Wall St. Rank hold SEM as of Q1 2026.

Wells Fargo held 43,438 shares of Select Medical worth $708K as of Q1 2026.
Wells Fargo sold 80,185 Select Medical shares in Q1 2026, an estimated $1.25M.
Select Medical made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3951 holding.
Wells Fargo first reported a position in Select Medical in Q2 2013 and has held it in 52 quarters since.
Wells Fargo's Select Medical position peaked at $17.9M in Q1 2016.
277 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.